news aktuell GmbHnews aktuell GmbH

TERRE DES FEMMES - Menschenrechte für die Frau e. V.: TERRE DES FEMMES launches the campaign “Abolish Paragraph 219a”. Spots point out the lunacy of this misogynic paragraph

Share
The campaign's key visual leaves no doubt about its goal. / Editorial use of this picture is free of charge. Please quote the source: "obs/TERRE DES FEMMES - Menschenrechte für die Frau e. V.
The campaign's key visual leaves no doubt about its goal. / Editorial use of this picture is free of charge. Please quote the source: "obs/TERRE DES FEMMES - Menschenrechte für die Frau e. V.

(Berlin, Germany): Paragraph 219a of the German Criminal Code (StGB) prohibits “advertising for abortion”. This paragraph is not confined to advertising but includes virtually any kind of information. In concrete terms, this means that doctors may only make public that they perform pregnancy terminations. But they may not provide information to the public on how they perform them. Otherwise, they are breaking the law and could face up to two years in prison, or a fine. And inadvertently pregnant women do not get the information they need.

In response to this situation, TERRE DES FEMMES is launching the “Abolish Paragraph 219a” campaign with the aim of making a significant contribution to education on abortion. Its unambiguous aim: Paragraph 219a must be struck from the German Criminal Code. “Women’s freedom for us is inextricably linked to their freedom to decide to terminate a pregnancy. With this campaign, we are aiming for the abolition of Paragraph 219a. Every woman must have the right to get access to professional information on abortion,” says Christa Stolle, the managing director of TERRE DES FEMMES. 

The campaign’s “heart” is the website www.abolish219a.com. TERRE DES FEMMES is collecting and publishing all the important information on the theme of abortion that doctors are not allowed to publish under current legislation. The information is available for downloading from the website in various formats, so that anyone will be able to distribute it to the women concerned and other interested parties, for example via social media channels. It contains emotional broadcasts and films in which non-professionals, such as a restaurateur, an announcer and a vehicle mechanic, share valuable information on abortion in support of the campaign to show how insane and misogynist Paragraph 219a is. These brief items highlight the absurdity that any non-professional is allowed to share information, while many doctors cannot. 

General practitioner Kristina Hänel, 64, is among the campaign’s prominent backers. She has been affected personally by the paragraph’s severe consequences. Hänel was convicted, despite an appeal to the Frankfurt higher regional court, for providing information on abortion procedures on her website. She then lodged an appeal on constitutional grounds, and the case is now pending before the German Constitutional Court in Karlsruhe. Kristina Hänel is conducting her court battle along with an appeal to the public: “I believe that it is important that everyone has the opportunity to provide information and education on abortion. Women thinking about the matter often find themselves in an emotional emergency. Access to reliable information would be hugely important to them.” 

Further information may be found at www.frauenrechte.de

Contacts

Images

The campaign's key visual leaves no doubt about its goal. / Editorial use of this picture is free of charge. Please quote the source: "obs/TERRE DES FEMMES - Menschenrechte für die Frau e. V.
The campaign's key visual leaves no doubt about its goal. / Editorial use of this picture is free of charge. Please quote the source: "obs/TERRE DES FEMMES - Menschenrechte für die Frau e. V.
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Additional partnership in medical technology: Bosch and R-Biopharm to strengthen Vivalytic analysis platform Plans to use innovative Bosch BioMEMS technology in PCR tests for multiresistant bacteria18.4.2024 10:15:00 CEST | Press release

Bosch and R-Biopharm are jointly investing 150 million euros in the development of new PCR tests and in marketing. PCR test for multiresistant gram-negative (MRGN) bacteria to be developed using novel BioMEMS technology. BioMEMS chips permit simultaneous testing of up to 250 genetic characteristics – in some cases, in less than 15 minutes. Darmstadt, Gerlingen, and Waiblingen, Germany – The market for medical technology is innovative, dynamic, and growing. Bosch sees medical technology as a strategic growth field and intends to expand its Bosch Healthcare Solutions subsidiary, based in Waiblingen. Bosch has now entered into a new partnership with the German diagnostics solutions company R-Biopharm. This partnership will be focused on Bosch’s universal, fully automated Vivalytic molecular diagnostic analysis platform. The two companies will invest a total of 150 million euros by the end of the decade. Within their strategic development and distribution partnership, the partners intend t

Elatec Brings Employee Badge for Apple Wallet to Users17.4.2024 08:45:03 CEST | Press release

Munich, April 17, 2024 – Elatec today announced it is bringing employee badge in Apple Wallet to its customers, enabling an organization’s employees or tenants to unlock access to locations and devices with a simple tap of their iPhone or Apple Watch. Powered by Elatec’s Mobile Credential Manager software, which works hand-in-hand with Elatec’s universal RFID readers, this brings together the world’s most powerful and versatile readers with the best mobile access system available. Employee badge in Apple Wallet helps deliver a convenient and contactless experience for users. Once enabled, employee badge in Apple Wallet allows users to seamlessly and securely add their employee badge to Apple Wallet, and hold their iPhone or Apple Watch near an NFC reader to unlock office doors, turnstiles, elevators and key card-protected amenity spaces — eliminating the need to open an app or present a traditional, plastic access key. With Express Mode, employees do not need to unlock their device to

National Research Center for Applied Cybersecurity ATHENE: Severe Vulnerabilities Discovered in Software to Protect Internet Routing12.4.2024 08:49:14 CEST | Press release

A research team from the National Research Center for Applied Cybersecurity ATHENE led by Prof. Dr. Haya Schulmann has uncovered 18 vulnerabilities in crucial software components of Resource Public Key Infrastructure (RPKI). RPKI is an Internet standard meant to protect Internet traffic from being hijacked by hackers. By now, all affected vendors provided patches for their products. The vulnerabilities could have had devastating consequences: Internet hijacks have already been exploited, e.g., for phishing passwords and other sensitive information, tricking certificate authorities into issuing fraudulent Web certificates, stealing cryptocurrency, distributing malware, and poisoning caches of DNS servers.

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment10.4.2024 11:00:00 CEST | Press release

The launch in Germany through its step-down subsidiary betapharm marks Dr. Reddy's entry into digital therapeutics in Europe. Nerivio® is the first REN (wearable, FDA-cleared, and CE-marked for acute and/or prevention migraine (with or without aura) treatment for adults and adolescents (≥ 12 years). Nerivio® is worn on the upper arm during treatment and controlled by a smartphone app, making it comfortable and portable. Starting with Germany, followed by Spain and the UK, Dr. Reddy's plans to further increase access to Nerivio® in European countries.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye